Skip to Content

C 432 (Darifenacin Hydrobromide Extended-Release 15 mg)

Pill with imprint C 432 is Peach, Round and has been identified as Darifenacin Hydrobromide Extended-Release 15 mg. It is supplied by Cipla USA Inc..

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 432

Darifenacin hydrobromide extended-release 15 mg C 432

Darifenacin Hydrobromide Extended-Release

Imprint
C 432
Strength
15 mg
Color
Peach
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0432
Inactive Ingredients
calcium phosphate dibasic anhydrous, hypromellose 2910 (3 mPa.s), magnesium stearate, magnesium silicate, titanium dioxide, polyethylene glycol 4000, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.